Arteris financials
$23.26+0.61%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $70.6M | $57.7M | $53.7M | $50.4M | $37.9M |
| Gross profit | $63.7M | $51.8M | $48.6M | $46.1M | $34.1M |
| Gross margin | 90.2% | 89.7% | 90.5% | 91.5% | 90.1% |
| Operating income | -$33.1M | -$31.6M | -$35.1M | -$28.9M | -$21.8M |
| Net income | -$34.7M | -$33.6M | -$36.9M | -$27.4M | -$23.4M |
| Net margin | −49.2% | −58.3% | −68.7% | −54.4% | −61.8% |
| Diluted EPS | $-0.82 | $-0.86 | $-1.03 | $-0.84 | $-1.06 |
| EBITDA | -$29.8M | -$28.2M | -$32.1M | -$26.8M | -$20.3M |
| Operating cash flow | $6.7M | -$720.0K | -$15.7M | -$6.8M | -$814.0K |
| Free cash flow | $5.3M | -$1.0M | -$17.2M | -$7.8M | -$1.6M |
| Diluted shares | 42.3M | 38.9M | 35.7M | 32.6M | 22.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $33.9M | $13.7M | $13.7M | $37.4M | $85.8M |
| Short-term investments | $20.7M | $30.2M | $27.5M | $30.7M | $0.00 |
| Total debt | $1.6M | $0.00 | $0.00 | $0.00 | $1.1M |
| Total assets | $115.0M | $106.1M | $102.8M | $115.5M | $120.4M |
| Total liabilities | $129.7M | $107.3M | $87.7M | $78.0M | $67.5M |
| Shareholders' equity | -$14.6M | -$1.2M | $15.1M | $37.5M | $52.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology